International Congenital Heart Disease Consortium

The International Congenital Heart Disease (CHD) Consortium is a global organization dedicated to studying and improving how congenital heart defects—birth defects affecting the heart—are diagnosed, treated, and managed. By collaborating across countries and institutions, it aims to share research, standardize care, and enhance outcomes for patients worldwide. The consortium helps medical professionals understand the best approaches, advances treatment options, and supports families affected by these heart conditions, ultimately striving to improve quality of life and survival rates for individuals with congenital heart disease.